Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
about
Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesDefining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Influenza vaccines: a moving interdisciplinary field.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase.An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Influenza immunology evaluation and correlates of protection: a focus on vaccines.Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesAnalysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineAntibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in miceStructural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Universal Influenza Vaccines: To Dream the Possible Dream?The application of virus-like particles as vaccines and biological vehicles.From Variation of Influenza Viral Proteins to Vaccine Development.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Kinetics, longevity and cross-reactivity of anti-neuraminidase antibody after natural infection with influenza A viruses.The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness
P2860
Q28387782-07AD32F4-15A6-4429-AC31-8587439CED2AQ30151352-4384A225-B72D-413D-9A42-65CFE2F32ED0Q30367695-E1BA152F-B725-4F1F-84C7-7CCDA99E41FDQ30372274-85F795D4-ABBB-41A7-97E0-727E7D94C5CCQ30373761-A14C3093-9A2E-4C2B-B969-A877A6B2EADEQ30377023-F60B3DB8-4B6E-4538-9A55-429BC29BEE41Q30380287-4A637710-8300-4777-BD19-E2D7371BE194Q30385397-69D64283-E311-4154-9151-BD28FBA5BEEAQ30386612-6FAE9342-D2A4-490E-A63E-47722B0B2594Q30386823-E55228B3-7568-4432-A294-D1C4A5318722Q30400179-B1ADF30A-9608-4780-AFA1-2D299A1E0F56Q30401056-951D686B-B41A-4813-A060-030B3ED4DBB7Q30425439-313A6A34-BD7D-4C19-AB0F-CDC5CBB3C89DQ30425783-F0BF5160-6778-468F-A6EE-20CE25B35CF6Q33820732-67D77822-8501-4539-B39C-EC75A2DE54F8Q34511080-D9EBBDEE-A918-42E8-94B3-EC49C31DB4BAQ34991399-48D579D0-D17E-402F-ABA4-18E44D9B9237Q35122785-1C233C82-B554-4981-AAF4-2350802115AAQ35139986-E960B4A7-1408-4F13-8FBB-2E6DAD756935Q35677624-87C81D90-4F95-4348-8C34-9C5A431DB3E4Q35826733-880EF0E7-C13B-42B1-B8CA-8A27B6E844D2Q36675360-6376F446-50F4-47BA-9A65-DED88ECC4E26Q38603912-BA1666F9-5688-4EE2-A92A-B20EC50CD1D1Q39441534-2F1AA0AD-DE89-4412-89DE-3A081F3692C0Q40075978-BD9A51D1-B2B1-497B-9619-309B3555534AQ41918783-5D28F106-58E1-4477-9830-5A78F1BD457DQ43673390-3F568FCA-BD5B-4150-9344-DDEE6D156838Q47108278-6B6FFD2B-BB66-41CE-B203-0E102C03C0A7Q47132783-D7B7A60F-1DD2-4224-BC74-A7D637D6B66BQ52609074-EF3194BE-6EAC-47D7-B588-767AF1EF8142Q55689231-736ED792-7ED3-498E-9E27-AB1C454D0915Q57094018-2F978F7D-B45E-4AEB-BF7F-840642680A05
P2860
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@ast
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@en
type
label
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@ast
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@en
prefLabel
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@ast
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@en
P2093
P2860
P50
P1433
P1476
Protection against a lethal H5 ...... ic H1N1 neuraminidase in mice.
@en
P2093
Hongquan Wan
John C Kash
Judith D Easterbrook
Laura Couzens
Louis M Schwartzman
P2860
P356
10.1016/J.VIROL.2012.06.003
P407
P577
2012-06-22T00:00:00Z